Skip to main content

Table 4 Univariate analysis of patient characteristics associated with 30 day all-cause mortality

From: Molecular epidemiology and outcome of carbapenem-resistant Enterobacterales in Saudi Arabia

Parameter

OR 95% CI

p-value

Age (years)

1.02 (1.01–1.04)

0.01

Charlson comorbidity index

1.20 (1.07–1.33)

0.001

Pitt bacteremia score

1.32 (1.15–1.50)

< 0.0001

APACHE II score

0.99 (0.95–1.02)

0.43

CLABSI

2.74 (1.21–6.22)

0.02

HAP/VAP

2.31 (1.15–4.64)

0.02

Complicated UTI

0.50 (0.22–1.12)

0.09

Complicated intra-abdominal infection

0.37 (0.14–1.03)

0.06

Skin and soft tissue infection

0.75 (0.26–2.17)

0.60

Joint/bone infection

< 0.001 (< 0.001–> 999.99)

0.98

Primary bacteremia (source unidentified)

2.17 (0.75–6.30)

0.15

CRE bacteremia

2.75 (1.45–5.21)

0.002

NDM

1.49 (0.67–3.31)

0.32

OXA48

1.35 (0.68–2.71)

0.39

Received CAZ-AVI

0.75 (0.40–1.40)

0.37

Cardiac disease

1.69 (0.81–3.55)

0.16

Diabetes Mellitus

2.02 (1.08–3.79)

0.03

Non-hematological malignancy

1.30 (0.22–3.37)

0.44

Hematological malignancy

0.86 (0.67–2.49)

0.83

Immunosuppressive medication

1.10 (0.52–2.32)

0.81

  1. OR odds ratio, CI confidence interval